Research with Pregnant Women
Recent News
Revised CIOMS guidelines were recently published (update from 2002 version). NTE members contributed (see above) as part of the open call for recommendations in the lead up to
Overview
While great strides have been made in recent history with respect to the inclusion of women and children in clinical trials, pregnant women are often routinely excluded. Pregnant women and their fetuses require safe, effective, evidence-based treatment. Excluding them from clinical trials forces their physicians to either withhold treatment or prescribe drugs “off-label”, without the benefit of clinical data to verify safe, effective and appropriate dosages for pregnant women and their fetuses.
This occurs despite guidelines promulgated by the Council for International Organizations of Medical Sciences (CIOMS) which clearly state that pregnant women should be included in research. [PDF - 1.7 MB] also states that women should not be excluded from research simply because they are pregnant or breastfeeding.
Françoise Baylis argued before the [PDF - 106 KB], "pregnant women get sick and sick women get pregnant", and they should be entitled to the same level of evidence-based healthcare as other individuals. Her concerns were noted in (page 16) [PDF - 1.5 MB], and also in (page 23) [PDF - 4.4 MB].
Françoise Baylis is co-editor with Angela Ballantyne of (Springer, 2016).
The debate has been heard in conference presentations, the media and academic journals:
- Pregnant Women and Health Research: An Ethical Imperative [PDF - 2.8 MB]
Françoise Baylis, presentation at Queen's University, May 7, 2013.
Anne Kingston, Macleans, April 29, 2013.- [PDF - 1.8 MB]
Françoise Baylis and Scott Halperin, Clinical Investigation, 2012, 2(2),139-146.
Chris Kaposy and Françoise Baylis, The American Journal of Bioethics, 2011, 11(5): 60-62.
Melinda Wenner Moyer, Body Politic, January 6, 2011.
Last updated September 2017.